Preload Image
Preload Image

Global Urinary Incontinence Products Market Outlook, 2030

The global Urinary Incontinence Products market size is predicted to grow from US$ 15460 million in 2025 to US$ 26710 million in 2031; it is expected to grow at a CAGR of 9.5% from

The global urinary incontinence products market is expected to witness significant growth by 2030, driven by an aging population, increasing awareness of personal health and hygiene, and advancements in healthcare infrastructure. Urinary incontinence, characterized by the involuntary leakage of urine, is a common condition affecting millions worldwide, particularly among the elderly and individuals with chronic illnesses. As life expectancy increases globally, the prevalence of age-related conditions such as incontinence has also risen, leading to a growing demand for reliable and discreet management solutions. The market for urinary incontinence products includes a wide range of items designed to offer comfort, absorbency, odor control, and convenience, such as adult diapers, pads, liners, guards, and catheters. Increased healthcare spending and improvements in product innovation have significantly enhanced the quality and effectiveness of incontinence products, making them more appealing to consumers across all demographics. Furthermore, public health initiatives and media campaigns have helped destigmatize the condition, encouraging individuals to seek treatment and use appropriate products. Retail pharmacies, supermarkets, and e-commerce platforms have also played a crucial role in improving access to these products, particularly in remote and underserved areas. As the market evolves, manufacturers are placing more emphasis on sustainable materials, skin-friendly formulations, and ergonomic design, aligning their offerings with consumer preferences for comfort, discretion, and environmental responsibility. Additionally, the rising incidence of obesity, diabetes, and post-surgical complications is contributing to increased cases of temporary or permanent incontinence, thereby reinforcing the demand for effective and accessible management options.

According to the publisher, the global Urinary Incontinence Products market size is predicted to grow from US$ 15460 million in 2025 to US$ 26710 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031. Advancements in medical technology, coupled with shifting consumer preferences, are transforming the way urinary incontinence is managed and perceived across the globe. Consumers are increasingly favoring products that integrate cutting-edge features such as moisture-wicking layers, pH-balanced liners, and breathable materials that reduce skin irritation and enhance comfort during prolonged wear. With innovations aiming to improve functionality and user experience, modern incontinence products have become more discreet, efficient, and adaptable to diverse lifestyle needs. The growing popularity of home-based healthcare services and personalized care regimens has also spurred demand for easy-to-use and reliable solutions that allow users to maintain independence and dignity. In addition to traditional disposable items, the market is seeing an uptrend in reusable alternatives, such as washable pads and underwear, which cater to environmentally conscious consumers seeking sustainable healthcare options. Healthcare providers are increasingly involved in recommending or supplying specific products tailored to patients’ medical conditions, which helps improve patient compliance and outcomes. Insurance coverage and reimbursement policies in developed regions are further promoting the use of clinically approved incontinence products, particularly in hospitals, eldercare centers, and long-term care facilities. Moreover, cultural shifts and increasing acceptance of discussions surrounding intimate health are encouraging younger demographics to proactively address mild or stress-related incontinence issues, opening new avenues for growth. Marketing strategies have also become more inclusive, reflecting a diverse range of users beyond the elderly, and digital platforms now serve as educational and retail hubs for incontinence-related solutions.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The urinary incontinence products market is segmented into urine absorbents, urine accepted products/incontinence bags, and others. Urine absorbents are designed to absorb and retain urine, preventing leakage and ensuring comfort for individuals with incontinence. These products include adult diapers, pads, and briefs, which are commonly used by both men and women. They are designed for high absorbency, skin protection, and odor control, making them ideal for managing moderate to severe incontinence. Urine accepted products/incontinence bags are specialized products designed for the collection of urine. These bags are often used for individuals with more severe incontinence, or those who may not be able to use traditional absorbents. They come in various forms, such as leg bags, belly bags, and larger drainage bags, which are often used with catheters. These products are particularly suitable for those who require a higher level of incontinence care or for individuals who may be bedridden. The others category includes specialized urinary products such as urinary catheters, external catheters, and skin care products, all designed to complement or enhance incontinence management. These items may include protective creams, wipes, and other medical aids that support hygiene, comfort, and skin health for individuals with urinary incontinence.

The urinary incontinence products market is widely applied in hospitals, homecare, nursing homes, and other settings. In hospitals, incontinence products are used to manage patients with temporary or permanent incontinence, particularly in intensive care units, geriatrics, or post-surgical recovery areas. Hospitals require high-quality, reliable products that offer comfort, hygiene, and protection for patients, especially those with limited mobility. In the homecare sector, urinary incontinence products are used by individuals who experience incontinence in the comfort of their own homes. These products, which include absorbents, incontinence bags, and specialized skin care solutions, enable individuals to maintain dignity and quality of life while managing their condition. Homecare products are often more discreet and designed for daily use. Nursing homes represent another significant application area, where urinary incontinence products are essential for managing the care of elderly residents. Incontinence products in nursing homes must offer comfort, reliability, and ease of use, as residents may have varying levels of mobility and cognitive abilities. These products also assist nursing home staff in providing more efficient care. The others category includes various niche applications such as incontinence care in rehabilitation centers, assisted living facilities, and palliative care units, where similar needs exist for managing urinary incontinence in a controlled, hygienic, and comfortable manner.

Considered in this report:
• Historic Year: 2019
• Base Year: 2024
• Estimated Year: 2025
• Forecast Year: 2030

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Priyanka Makwana

Priyanka Makwana

Industry Research Analyst



Aspects covered in this report:
• Global Urinary Incontinence Products Market with its value and forecast along with its segments
• Major drivers and restraints influencing market dynamics
• Current trends and technological advancements shaping industry growth
• Key companies profiled in the market landscape
• Strategic recommendations for industry stakeholders

By Type:
• Urine Absorbents
• Urine Accepted Products/ Incontinence Bags
• Others

By Application:
• Hospital
• Homecare
• Nursing Homes
• Others

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Priyanka Makwana


The approach of the report:
This report utilizes a mixed-method research strategy, combining both secondary and primary research to deliver comprehensive insights. The initial stage involved reviewing secondary data from authentic sources such as medical journals, healthcare databases, company publications, and public health agency reports to establish market context. Following this, primary research was conducted through interviews and surveys with key stakeholders including healthcare professionals, product managers, procurement heads, and caregivers. End-user feedback was collected across various regions and healthcare environments, segmented by gender, age group, and product preference. All primary data were validated against secondary research to ensure consistency, reliability, and depth of insight.

Intended audience:
This report is essential for medical device manufacturers, healthcare providers, pharmaceutical distributors, geriatric care agencies, and hospital procurement teams aiming to understand growth opportunities in the urinary incontinence products market. It is equally beneficial for policy-makers, investors, and insurance companies seeking data-driven strategies for healthcare budgeting and planning. Beyond business use, the findings are also valuable for academic institutions, market analysts, and public health organizations to enhance awareness and promote product innovation tailored to aging populations and growing chronic disease cases.

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Urinary Incontinence Products Annual Sales 2020-2031
  • 2.1.2 World Current & Future Analysis for Urinary Incontinence Products by Geographic Region, 2020, 2024 & 2031
  • 2.1.3 World Current & Future Analysis for Urinary Incontinence Products by Country/Region, 2020, 2024 & 2031
  • 2.2 Urinary Incontinence Products Segment by Type
  • 2.2.1 Urine Absorbents
  • 2.2.2 Urine Accepted Products/ Incontinence Bags
  • 2.2.3 Others
  • 2.3 Urinary Incontinence Products Sales by Type
  • 2.3.1 Global Urinary Incontinence Products Sales Market Share by Type (2020-2025)
  • 2.3.2 Global Urinary Incontinence Products Revenue and Market Share by Type (2020-2025)
  • 2.3.3 Global Urinary Incontinence Products Sale Price by Type (2020-2025)
  • 2.4 Urinary Incontinence Products Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Homecare
  • 2.4.3 Nursing Homes
  • 2.4.4 Others
  • 2.5 Urinary Incontinence Products Sales by Application
  • 2.5.1 Global Urinary Incontinence Products Sale Market Share by Application (2020-2025)
  • 2.5.2 Global Urinary Incontinence Products Revenue and Market Share by Application (2020-2025)
  • 2.5.3 Global Urinary Incontinence Products Sale Price by Application (2020-2025)
  • 3 Global by Company
  • 3.1 Global Urinary Incontinence Products Breakdown Data by Company
  • 3.1.1 Global Urinary Incontinence Products Annual Sales by Company (2020-2025)
  • 3.1.2 Global Urinary Incontinence Products Sales Market Share by Company (2020-2025)
  • 3.2 Global Urinary Incontinence Products Annual Revenue by Company (2020-2025)
  • 3.2.1 Global Urinary Incontinence Products Revenue by Company (2020-2025)
  • 3.2.2 Global Urinary Incontinence Products Revenue Market Share by Company (2020-2025)
  • 3.3 Global Urinary Incontinence Products Sale Price by Company
  • 3.4 Key Manufacturers Urinary Incontinence Products Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Urinary Incontinence Products Product Location Distribution
  • 3.4.2 Players Urinary Incontinence Products Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
  • 3.6 New Products and Potential Entrants
  • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Urinary Incontinence Products by Geographic Region
  • 4.1 World Historic Urinary Incontinence Products Market Size by Geographic Region (2020-2025)
  • 4.1.1 Global Urinary Incontinence Products Annual Sales by Geographic Region (2020-2025)
  • 4.1.2 Global Urinary Incontinence Products Annual Revenue by Geographic Region (2020-2025)
  • 4.2 World Historic Urinary Incontinence Products Market Size by Country/Region (2020-2025)
  • 4.2.1 Global Urinary Incontinence Products Annual Sales by Country/Region (2020-2025)
  • 4.2.2 Global Urinary Incontinence Products Annual Revenue by Country/Region (2020-2025)
  • 4.3 Americas Urinary Incontinence Products Sales Growth
  • 4.4 APAC Urinary Incontinence Products Sales Growth
  • 4.5 Europe Urinary Incontinence Products Sales Growth
  • 4.6 Middle East & Africa Urinary Incontinence Products Sales Growth
  • 5 Americas
  • 5.1 Americas Urinary Incontinence Products Sales by Country
  • 5.1.1 Americas Urinary Incontinence Products Sales by Country (2020-2025)
  • 5.1.2 Americas Urinary Incontinence Products Revenue by Country (2020-2025)
  • 5.2 Americas Urinary Incontinence Products Sales by Type (2020-2025)
  • 5.3 Americas Urinary Incontinence Products Sales by Application (2020-2025)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Urinary Incontinence Products Sales by Region
  • 6.1.1 APAC Urinary Incontinence Products Sales by Region (2020-2025)
  • 6.1.2 APAC Urinary Incontinence Products Revenue by Region (2020-2025)
  • 6.2 APAC Urinary Incontinence Products Sales by Type (2020-2025)
  • 6.3 APAC Urinary Incontinence Products Sales by Application (2020-2025)
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Urinary Incontinence Products by Country
  • 7.1.1 Europe Urinary Incontinence Products Sales by Country (2020-2025)
  • 7.1.2 Europe Urinary Incontinence Products Revenue by Country (2020-2025)
  • 7.2 Europe Urinary Incontinence Products Sales by Type (2020-2025)
  • 7.3 Europe Urinary Incontinence Products Sales by Application (2020-2025)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Urinary Incontinence Products by Country
  • 8.1.1 Middle East & Africa Urinary Incontinence Products Sales by Country (2020-2025)
  • 8.1.2 Middle East & Africa Urinary Incontinence Products Revenue by Country (2020-2025)
  • 8.2 Middle East & Africa Urinary Incontinence Products Sales by Type (2020-2025)
  • 8.3 Middle East & Africa Urinary Incontinence Products Sales by Application (2020-2025)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Urinary Incontinence Products
  • 10.3 Manufacturing Process Analysis of Urinary Incontinence Products
  • 10.4 Industry Chain Structure of Urinary Incontinence Products
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Urinary Incontinence Products Distributors
  • 11.3 Urinary Incontinence Products Customer
  • 12 World Forecast Review for Urinary Incontinence Products by Geographic Region
  • 12.1 Global Urinary Incontinence Products Market Size Forecast by Region
  • 12.1.1 Global Urinary Incontinence Products Forecast by Region (2026-2031)
  • 12.1.2 Global Urinary Incontinence Products Annual Revenue Forecast by Region (2026-2031)
  • 12.2 Americas Forecast by Country (2026-2031)
  • 12.3 APAC Forecast by Region (2026-2031)
  • 12.4 Europe Forecast by Country (2026-2031)
  • 12.5 Middle East & Africa Forecast by Country (2026-2031)
  • 12.6 Global Urinary Incontinence Products Forecast by Type (2026-2031)
  • 12.7 Global Urinary Incontinence Products Forecast by Application (2026-2031)
  • 13 Key Players Analysis
  • 13.1 Kimberly-Clark
  • 13.1.1 Kimberly-Clark Company Information
  • 13.1.2 Kimberly-Clark Urinary Incontinence Products Product Portfolios and Specifications
  • 13.1.3 Kimberly-Clark Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.1.4 Kimberly-Clark Main Business Overview
  • 13.1.5 Kimberly-Clark Latest Developments
  • 13.2 SCA
  • 13.2.1 SCA Company Information
  • 13.2.2 SCA Urinary Incontinence Products Product Portfolios and Specifications
  • 13.2.3 SCA Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.2.4 SCA Main Business Overview
  • 13.2.5 SCA Latest Developments
  • 13.3 Unicharm
  • 13.3.1 Unicharm Company Information
  • 13.3.2 Unicharm Urinary Incontinence Products Product Portfolios and Specifications
  • 13.3.3 Unicharm Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.3.4 Unicharm Main Business Overview
  • 13.3.5 Unicharm Latest Developments
  • 13.4 Procter & Gamble
  • 13.4.1 Procter & Gamble Company Information
  • 13.4.2 Procter & Gamble Urinary Incontinence Products Product Portfolios and Specifications
  • 13.4.3 Procter & Gamble Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.4.4 Procter & Gamble Main Business Overview
  • 13.4.5 Procter & Gamble Latest Developments
  • 13.5 First Quality Enterprises
  • 13.5.1 First Quality Enterprises Company Information
  • 13.5.2 First Quality Enterprises Urinary Incontinence Products Product Portfolios and Specifications
  • 13.5.3 First Quality Enterprises Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.5.4 First Quality Enterprises Main Business Overview
  • 13.5.5 First Quality Enterprises Latest Developments
  • 13.6 Domtar
  • 13.6.1 Domtar Company Information
  • 13.6.2 Domtar Urinary Incontinence Products Product Portfolios and Specifications
  • 13.6.3 Domtar Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.6.4 Domtar Main Business Overview
  • 13.6.5 Domtar Latest Developments
  • 13.7 Medline
  • 13.7.1 Medline Company Information
  • 13.7.2 Medline Urinary Incontinence Products Product Portfolios and Specifications
  • 13.7.3 Medline Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.7.4 Medline Main Business Overview
  • 13.7.5 Medline Latest Developments
  • 13.8 3M
  • 13.8.1 3M Company Information
  • 13.8.2 3M Urinary Incontinence Products Product Portfolios and Specifications
  • 13.8.3 3M Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.8.4 3M Main Business Overview
  • 13.8.5 3M Latest Developments
  • 13.9 Medtronic
  • 13.9.1 Medtronic Company Information
  • 13.9.2 Medtronic Urinary Incontinence Products Product Portfolios and Specifications
  • 13.9.3 Medtronic Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.9.4 Medtronic Main Business Overview
  • 13.9.5 Medtronic Latest Developments
  • 13.10 B Braun
  • 13.10.1 B Braun Company Information
  • 13.10.2 B Braun Urinary Incontinence Products Product Portfolios and Specifications
  • 13.10.3 B Braun Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.10.4 B Braun Main Business Overview
  • 13.10.5 B Braun Latest Developments
  • 13.11 Cotton Incorporated
  • 13.11.1 Cotton Incorporated Company Information
  • 13.11.2 Cotton Incorporated Urinary Incontinence Products Product Portfolios and Specifications
  • 13.11.3 Cotton Incorporated Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.11.4 Cotton Incorporated Main Business Overview
  • 13.11.5 Cotton Incorporated Latest Developments
  • 13.12 Tranquility
  • 13.12.1 Tranquility Company Information
  • 13.12.2 Tranquility Urinary Incontinence Products Product Portfolios and Specifications
  • 13.12.3 Tranquility Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.12.4 Tranquility Main Business Overview
  • 13.12.5 Tranquility Latest Developments
  • 13.13 Hengan Group
  • 13.13.1 Hengan Group Company Information
  • 13.13.2 Hengan Group Urinary Incontinence Products Product Portfolios and Specifications
  • 13.13.3 Hengan Group Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.13.4 Hengan Group Main Business Overview
  • 13.13.5 Hengan Group Latest Developments
  • 13.14 Coco
  • 13.14.1 Coco Company Information
  • 13.14.2 Coco Urinary Incontinence Products Product Portfolios and Specifications
  • 13.14.3 Coco Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.14.4 Coco Main Business Overview
  • 13.14.5 Coco Latest Developments
  • 13.15 Chiaus
  • 13.15.1 Chiaus Company Information
  • 13.15.2 Chiaus Urinary Incontinence Products Product Portfolios and Specifications
  • 13.15.3 Chiaus Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.15.4 Chiaus Main Business Overview
  • 13.15.5 Chiaus Latest Developments
  • 13.16 Fuburg
  • 13.16.1 Fuburg Company Information
  • 13.16.2 Fuburg Urinary Incontinence Products Product Portfolios and Specifications
  • 13.16.3 Fuburg Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.16.4 Fuburg Main Business Overview
  • 13.16.5 Fuburg Latest Developments
  • 13.17 AAB Group
  • 13.17.1 AAB Group Company Information
  • 13.17.2 AAB Group Urinary Incontinence Products Product Portfolios and Specifications
  • 13.17.3 AAB Group Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.17.4 AAB Group Main Business Overview
  • 13.17.5 AAB Group Latest Developments
  • 13.18 Coloplast
  • 13.18.1 Coloplast Company Information
  • 13.18.2 Coloplast Urinary Incontinence Products Product Portfolios and Specifications
  • 13.18.3 Coloplast Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.18.4 Coloplast Main Business Overview
  • 13.18.5 Coloplast Latest Developments
  • 13.19 ConvaTec
  • 13.19.1 ConvaTec Company Information
  • 13.19.2 ConvaTec Urinary Incontinence Products Product Portfolios and Specifications
  • 13.19.3 ConvaTec Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.19.4 ConvaTec Main Business Overview
  • 13.19.5 ConvaTec Latest Developments
  • 13.20 Flexicare Medical
  • 13.20.1 Flexicare Medical Company Information
  • 13.20.2 Flexicare Medical Urinary Incontinence Products Product Portfolios and Specifications
  • 13.20.3 Flexicare Medical Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.20.4 Flexicare Medical Main Business Overview
  • 13.20.5 Flexicare Medical Latest Developments
  • 13.21 Hollister
  • 13.21.1 Hollister Company Information
  • 13.21.2 Hollister Urinary Incontinence Products Product Portfolios and Specifications
  • 13.21.3 Hollister Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.21.4 Hollister Main Business Overview
  • 13.21.5 Hollister Latest Developments
  • 13.22 Marlen Manufacturing & Development
  • 13.22.1 Marlen Manufacturing & Development Company Information
  • 13.22.2 Marlen Manufacturing & Development Urinary Incontinence Products Product Portfolios and Specifications
  • 13.22.3 Marlen Manufacturing & Development Urinary Incontinence Products Sales, Revenue, Price and Gross Margin (2020-2025)
  • 13.22.4 Marlen Manufacturing & Development Main Business Overview
  • 13.22.5 Marlen Manufacturing & Development Latest Developments
  • 14 Research Findings and Conclusion

Logo

Global Urinary Incontinence Products Market Outlook, 2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.